These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6856049)

  • 21. A comparative electrophysiological and biochemical assessment of serotonin (5-HT) and a novel 5-HT agonist (MK-212) on central serotonergic receptors.
    Yarbrough GG; Singh DK; Pettibone DJ
    Neuropharmacology; 1984 Nov; 23(11):1271-7. PubMed ID: 6527736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
    Godbout R; Chaput Y; Blier P; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):679-90. PubMed ID: 1681446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of 5-hydroxytryptamine receptors by quipazine.
    Lansdown MJ; Nash HL; Preston PR; Wallis DI; Williams RG
    Br J Pharmacol; 1980 Mar; 68(3):525-32. PubMed ID: 7052342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorder.
    Zghoul T; Blier P
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):13-21. PubMed ID: 12899732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LSD and 2-bromo-LSD: comparison on effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala.
    Aghajanian GK
    Neuropharmacology; 1976 Sep; 15(9):521-8. PubMed ID: 10535
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo electrophysiological assessment of the agonistic properties of flibanserin at pre- and postsynaptic 5-HT1A receptors in the rat brain.
    Rueter LE; de Montigny C; Blier P
    Synapse; 1998 Aug; 29(4):392-405. PubMed ID: 9661257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; de Montigny C; Blier P
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
    Haddjeri N; Blier P
    J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of an autoreceptor modulating the release of [3H]5-hydroxytryptamine from a synaptosomal-rich spinal cord tissue preparation.
    Monroe PJ; Smith DJ
    J Neurochem; 1985 Dec; 45(6):1886-94. PubMed ID: 3877146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced stimulus control and the concept of breaking point: LSD and quipazine.
    Winter JC
    Psychopharmacology (Berl); 1981; 72(2):217-8. PubMed ID: 6782615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):303-11. PubMed ID: 9303566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of LSD on Ca++ currents in central 5-HT-containing neurons: 5-HT1A receptors may play a role in hallucinogenesis.
    Penington NJ; Fox AP
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1160-5. PubMed ID: 8014859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin-like actions of quipazine and CPP on spinal motoneurones.
    Neuman RS; White SR
    Eur J Pharmacol; 1982 Jun; 81(1):49-56. PubMed ID: 7117370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
    Jackson DA; White SR
    Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
    Freo U; Holloway HW; Greig NH; Soncrant TT
    Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.